The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria
Estimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high quality, patient-level data required for global est...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2020
|
| _version_ | 1826259147507630080 |
|---|---|
| author | Dunachie, SJ Day, NP Dolecek, C |
| author_facet | Dunachie, SJ Day, NP Dolecek, C |
| author_sort | Dunachie, SJ |
| collection | OXFORD |
| description | Estimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high quality, patient-level data required for global estimates is challenging. Capacity for accurate microbiology culture and antimicrobial susceptibility testing is woefully neglected in low and middle-income countries, and further surveillance and research on community antimicrobial usage, bias in blood culture sampling, and the contribution of co-morbidities such as diabetes is essential. International collaboration between governments, policy makers, academics, microbiologists, front-line clinicians, veterinarians, the food and agriculture industry and the public is critical to understand and tackle AMR. |
| first_indexed | 2024-03-06T18:45:16Z |
| format | Journal article |
| id | oxford-uuid:0e49324a-faad-4213-b50d-97dc7b3c718a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:45:16Z |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:0e49324a-faad-4213-b50d-97dc7b3c718a2022-03-26T09:45:12ZThe challenges of estimating the human global burden of disease of antimicrobial resistant bacteriaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0e49324a-faad-4213-b50d-97dc7b3c718aEnglishSymplectic ElementsElsevier2020Dunachie, SJDay, NPDolecek, CEstimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high quality, patient-level data required for global estimates is challenging. Capacity for accurate microbiology culture and antimicrobial susceptibility testing is woefully neglected in low and middle-income countries, and further surveillance and research on community antimicrobial usage, bias in blood culture sampling, and the contribution of co-morbidities such as diabetes is essential. International collaboration between governments, policy makers, academics, microbiologists, front-line clinicians, veterinarians, the food and agriculture industry and the public is critical to understand and tackle AMR. |
| spellingShingle | Dunachie, SJ Day, NP Dolecek, C The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria |
| title | The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria |
| title_full | The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria |
| title_fullStr | The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria |
| title_full_unstemmed | The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria |
| title_short | The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria |
| title_sort | challenges of estimating the human global burden of disease of antimicrobial resistant bacteria |
| work_keys_str_mv | AT dunachiesj thechallengesofestimatingthehumanglobalburdenofdiseaseofantimicrobialresistantbacteria AT daynp thechallengesofestimatingthehumanglobalburdenofdiseaseofantimicrobialresistantbacteria AT dolecekc thechallengesofestimatingthehumanglobalburdenofdiseaseofantimicrobialresistantbacteria AT dunachiesj challengesofestimatingthehumanglobalburdenofdiseaseofantimicrobialresistantbacteria AT daynp challengesofestimatingthehumanglobalburdenofdiseaseofantimicrobialresistantbacteria AT dolecekc challengesofestimatingthehumanglobalburdenofdiseaseofantimicrobialresistantbacteria |